Ani Pharmaceuticals (ANIP) Change in Accured Expenses (2010 - 2018)
Ani Pharmaceuticals (ANIP) posted Change in Accured Expenses of $1.0 million for Q3 2018, up 236.72% sequentially from -$749000.0 in Q2 2018, and down 43.14% YoY from $1.8 million in Q3 2017.
Ani Pharmaceuticals (ANIP) Change in Accured Expenses (2010 - 2018) Analysis & Trends
Ani Pharmaceuticals has reported Change in Accured Expenses for 9 years, with the latest figure at $1.0 million in Q3 2018.
- Quarterly Change in Accured Expenses fell 43.14% year-over-year to $1.0 million in Q3 2018, while the trailing twelve-month figure through Sep 2018 was $174000.0 (up 74.0% YoY) and the FY2017 annual result came in at $644000.0, down 31.49% from the prior year.
- Change in Accured Expenses rose to $1.0 million in Q3 2018 per ANIP's latest filing, from -$749000.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $1.8 million in Q3 2017 and troughed at -$1.9 million in Q4 2015.
- A 5-year average of $171473.7 and a median of $143000.0 in 2014 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2015 and 2017: Change in Accured Expenses slumped 523.08% in 2015, then jumped 45125.0% in 2017.
- Over 5 years, Change in Accured Expenses stood at -$630000.0 in 2014, then plunged by 198.57% to -$1.9 million in 2015, then rose by 8.88% to -$1.7 million in 2016, then jumped by 31.74% to -$1.2 million in 2017, then jumped by 187.52% to $1.0 million in 2018.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered $1.0 million, -$749000.0, and $1.1 million for Q3 2018, Q2 2018, and Q1 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 82.00 Mn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | 142.00 Mn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -219.00 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | -4.00 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | -8.50 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 1.02 Mn |
| Sep 30, 2018 | 1.02 Mn |
| Jun 30, 2018 | -749,000.00 |
| Jun 30, 2018 | -749,000.00 |
| Mar 31, 2018 | 1.07 Mn |
| Mar 31, 2018 | 1.07 Mn |
| Dec 31, 2017 | -1.17 Mn |
| Dec 31, 2017 | -1.17 Mn |
| Sep 30, 2017 | 1.80 Mn |
| Sep 30, 2017 | 1.80 Mn |
| Jun 30, 2017 | -1.15 Mn |
| Jun 30, 2017 | -1.15 Mn |
| Mar 31, 2017 | 1.16 Mn |
| Mar 31, 2017 | 1.16 Mn |
| Dec 31, 2016 | -1.71 Mn |
| Dec 31, 2016 | -1.71 Mn |
| Sep 30, 2016 | -4,000.00 |
| Sep 30, 2016 | -4,000.00 |
| Jun 30, 2016 | 1.55 Mn |
| Jun 30, 2016 | 1.55 Mn |